Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00399893 · ClinicalTrials.gov registry record · NA
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT00399893 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 5 participants.
The verdict
NCT00399893, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate over a 6 month period the effect of octreotide therapy on food intake, sense of hunger, body weight, body composition, efficiency of burning calories, biomarkers of weight regulation and growth hormone markers in children and young Adults with Prader-Willi Syndrome(PWS).
Interventions
- DRUG Placebo
- DRUG Octreotide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2006-12 |
| Est. Completion | 2010-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00399893
The ClinicalTrials.gov registry entry for NCT00399893 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00399893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00399893 about?
NCT00399893 is a clinical study titled "Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)". The purpose of this study is to investigate over a 6 month period the effect of octreotide therapy on food intake, sense of hunger, body weight, body composition, efficiency of burning calories, biomarkers of weight regulation and growth hormone markers in children and young Adults with Prader-Willi...
What is the current status of trial NCT00399893?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2006-12. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00399893?
The interventions under investigation include: Placebo (DRUG), Octreotide (DRUG).
Who is sponsoring clinical trial NCT00399893?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.